Clinical Trials and Neuroendocrine Tumours

Please add your voice to our Clinical Trials and Neuroendocrine Tumour (NET) survey.

The Unicorn Foundation wants to see more clinical trials open for NET patients. We also want to understand what barriers stop people from participating in them. Your responses to this survey will help us work with our partners to achieve this and we value your input.
You will probably already have some ideas about clinical trials and we’ll explain more as you work your way through the survey. 

One of the barriers to clinical trials in NETs is recruiting patients due to the smaller numbers of diagnosed when comparing to more common cancers. We think that although it is difficult to recruit the appropriate numbers, this difficulty can be overcome with your help. Let us know what your understanding is of how trials work; what would encourage you to participate in a trial; and what would be the best ways to communicate with you about upcoming trials. 

The survey will be open for two months and we hope to get a cross section of our group so that we can help to make more informed decisions and encourage more stakeholders to invest in research in our NET Community.

It should only take you 5min-10mins and your assistance will be invaluable, simply click here to get started!

Thank you!

Share this post

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

Related Posts

INFO4NETs Online Resource now Live.

The much anticipated INFO4NETs platform (trial phase) is now LIVE and we are calling on our Neuroendocrine Cancer community to provide feedback. Developed by Dr